Dennis Giesing
Vorstandsvorsitzender bei CepheidRX LLC
Vermögen: - $ am 30.04.2024
Profil
Dennis H.
Giesing is the founder of CepheidRX LLC.
He previously worked as the Head of Research & Development at Cortria Corp.
and as the Chief Scientific Officer at TARIS BioMedical LLC.
From 2021 to 2023, he served as the Chief Development Officer at Immunome, Inc. In 2002 to 2004, he held the position of Senior Vice President-Lead Optimization at Aventis Pharmaceuticals, Inc. He also worked as a Principal at Marion Merrell Dow, Inc. and Vaneltix Pharma, Inc. Additionally, he held positions as a Principal at Marion Laboratories and Hoechst Marion Roussel, Inc. Prior to founding CepheidRX LLC, he was the Head of Pharmaceutical Development at MediVector, Inc. Dr. Giesing obtained his undergraduate and doctorate degrees from the University of Missouri-Kansas City.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOME, INC.
-.--% | 08.06.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Dennis Giesing
| Unternehmen | Position | Beginn |
|---|---|---|
| CepheidRX LLC | Vorstandsvorsitzender | 24.07.2009 |
Ehemalige bekannte Positionen von Dennis Giesing
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUNOME, INC. | Corporate Officer/Principal | 02.10.2023 |
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 30.10.2008 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.01.2004 |
| MediVector, Inc. | Corporate Officer/Principal | - |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Dennis Giesing
| University of Missouri-Kansas City | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Cortria Corp.
 Cortria Corp. Pharmaceuticals: MajorHealth Technology Cortria Corp. operates as a clinical-stage pharmaceutical company that focuses on developing medicines to fight cardiovascular disease. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in August 2005 and is headquartered in Needham, MA. | Health Technology |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
| Marion Merrell Dow, Inc. | Health Technology |
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Health Technology |
| Marion Laboratories | Distribution Services |
| Hoechst Marion Roussel, Inc. | |
| MediVector, Inc. | |
| CepheidRX LLC |
